[EN] COMPOUNDS AND COMPOSITIONS AS LXR MODULATORS<br/>[FR] COMPOSES ET COMPOSITIONS CONVENANT COMME MODULATEURS DES LXR
申请人:IRM LLC
公开号:WO2005077122A2
公开(公告)日:2005-08-25
The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of liver X receptors (LXRs).